...
首页> 外文期刊>Hematology Reports >Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPa) p42 versus p30 may contribute in part, to aberrant C/EBPa activity in acute leukemias
【24h】

Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPa) p42 versus p30 may contribute in part, to aberrant C/EBPa activity in acute leukemias

机译:sumoylation对CCAAT增强子结合蛋白α(C / EBPa)p42和p30活性的差异影响可能部分促成急性白血病中C / EBPa异常活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In this study, we have examined the role of post-translational modification of the myeloid master regulator C/EBP? by small ubiquitin-related modifier (SUMO). We have used transient transfection analysis, oligonucleotide pulldown assays and chromatin immunoprecititation in all-trans retinoic acid (ATRA)-inducible promyelocytic cell lines MPRO and NB4. We demonstrate that sumoylated wildtype p42-C/EBP??is associated with negative regulation of the myeloid specific lactoferrin (LF) gene in early myeloid cells and that a reduction in p42-C/EBP? sumoylation coincides with expression of the LF gene in maturing myeloid cells. In the acute promyelocytic leukemia cell line NB4 however, sumoylated p42 remains persistently bound to the LF promoter following ATRA-induction. This correlates with lack of lactoferrin expression in these cells. Changes in sumoylation status of C/EBP? thus appear to contribute to a switch that regulates transcriptional activity of this master regulator during normal neutrophil development. We also demonstrate that sumoylation of the AML associated dominant negative p30-C/EBP? isoform does not alter transactivation activity of the LF promoter. This may be because the p30 C/EBP? isoform binds to the LF promoter much less efficiently than its full length counterpart. Our data suggest that the activity of p42-C/EBP? in the developing neutrophil is more sensitive to changes in sumoylation than the p30 isoform. This difference may contribute to the leukemogenic potential of p30-C/EBP?.
机译:在这项研究中,我们检查了髓样主调节因子C / EBP的翻译后修饰的作用。泛素相关修饰剂(SUMO)。我们已在全反式维甲酸(ATRA)诱导的早幼粒细胞系MPRO和NB4中使用了瞬时转染分析,寡核苷酸下拉测定和染色质免疫沉淀。我们证明了磺酰化的野生型p42-C / EBP 14与早期髓样细胞中的髓样特异性乳铁蛋白(LF)基因的负调控有关,并且p42-C / EBP 3的减少。 sumoylation与成熟的髓样细胞中LF基因的表达相吻合。然而,在急性早幼粒细胞白血病细胞系NB4中,磺酰化的p42在ATRA诱导后仍与LF启动子持久结合。这与这些细胞中缺乏乳铁蛋白表达有关。 C / EBP的磺酰化状态变化?因此似乎在正常嗜中性粒细胞发育过程中有助于调节该主调节子的转录活性的开关。我们还证明了AML相关显性阴性p30-C / EBP的sumoylation吗?亚型不改变LF启动子的反式激活活性。这可能是因为p30 C / EBP?同工型与LF启动子的结合效率远低于其全长对应物。我们的数据表明p42-C / EBP的活性?与p30同工型相比,正在发育中的中性粒细胞中的α-氨基丁酸对磺酰基化的变化更敏感。这种差异可能有助于p30-C /EBPβ的致白血病潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号